The manufacturer cash route is NovoCare self-pay. The pen costs $199 for each of the first two fills at 0.25 or 0.5 mg, then $349/month at any dose up to 2.4 mg. The Wegovy tablet (FDA-approved December 2025) starts at $149/month but rises with the dose. Both are well under the ~$1,349/month list price you would pay at a pharmacy counter with no program.
The Wegovy Savings Card can drop the copay to as little as $25, but it only works with commercial insurance that covers Wegovy — it does nothing if you are uninsured. Compounded semaglutide via licensed telehealth runs about $99–$300/month (the low end is a 12-month plan billed upfront) and is not FDA-approved as a finished drug.
Enroll or check current cash pricing at novocare.com or 1-888-693-6489. Prices are estimates as of September 2026 and change without notice; the introductory vs. maintenance distinction matters, so confirm which tier applies to your dose.